Answers are grounded in this paper and cite their sources.
Background Organic acidurias are a heterogeneous group of inborn errors of metabolism (IEM) characterized by the accumulation of metabolites due to enzyme or transporter defects. Urine organic acid (UOA) analysis is a key biochemical genetics test for many IEMs. However, UOA procedures remain poorly harmonized, and proficiency testing data reveal substantial interlaboratory variation in performance. We evaluated current UOA practices to identify barriers to quality improvement and highlighted opportunities for harmonization. Method A structured questionnaire was used to capture key UOA workflows such as instrumentation, specimen rejection criteria, and quality assurance practices. Results Participating laboratories ( n = 32) reported moderate-to-high annual volumes (501–1000 tests in 38.7% and > 1000 in 32.3%), with analytical runtimes of 31–60 min per specimen. Creatinine normalization was the primary strategy for urine concentration adjustment, and visible contamination was the common reason for specimen rejection (43.1%). Quantitative practices varied: 63.4% quantified a subset or all analytes, whereas 36.7% relied on qualitative review. Interpretation was specialist-driven, with biochemical geneticists, clinical chemists, and pathologists accounting for 86.7%. Clinical information was inconsistently available for interpretation, and approaches to obtaining missing information varied. Difficult-to-analyze UOA included 3-hydroxyglutaric acid, mevalonolactone, and succinylacetone. Co-elution was the most common challenge, followed by recovery problems. Conclusions Biochemical genetics laboratories use a common core approach to UOA testing, based on GC–MS and trimethylsilyl derivatization. However, variability remains in specimen acceptance, pretreatment, oximation, quantitation, quality control, and interpretation. Our findings identify targets for harmonization, including biochemical genetics expert guidelines for preanalytical, analytical, and postanalytical steps.
No takes yet. Share an insight, caveat, or question.
Amankwaa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: